Rheumatology News
- CMSC 2023 Ozanimod for Relapsing MS Shows Long-Term Safety, Efficacy
- Alert EU Approves Bimekizumab for PsA and AxSpA
- Is ChatGPT a Friend or Foe of Medical Publishing?
- Gout Linked to Smaller Brain Volume, Neurodegeneration Risk
- Long COVID Risk Not Higher With Rheumatic Diseases
- EULAR 2023 Uricase-Based Gout Drug Meets Endpoints in Phase 3 Trials
- EULAR 2023 Nuances in Efficacy, MACE Risk Revealed Between JAKi, TNFi
- EULAR 2023 Early AxSpA Diagnosis Stable in Most Referred Patients
- EULAR 2023 EULAR SSc Recommendations Now Include Immunosuppressants
- EULAR 2023 URAT1 Inhibitor Shows 'Substantial' Cut in Uric Acid in Gout
- EULAR 2023 RA and Demyelinating Disease: No Consistent Link to TNFi
- EULAR 2023 AI Efforts Make Strides in Predicting Progression to RA
- EULAR 2023 Promising Telitacicept Results Reported for Lupus, Sjögren's
- 7 Tactics to Reduce EHR Tasks and Save Time
- MDs With Chronic Illness Live in a Different Medical World
- Scientists Discover Genomic Variants for Rare Skin Disease
- DDW 2023 Biologic-to-Biosimilar Switches Deemed Safe and Effective
- EULAR 2023 ILD Risk Elevated in RA, PsA After Starting DMARDs
- EULAR 2023 Two Biologics Show No Difference in Axial Spondyloarthritis
- EULAR 2023 Lupus Nephritis: Hopes, Questions Arise for Baricitinib